1 year return (CAGR)
-
Parabilis Medicines, Inc. Common Stock Exchange (NASDAQ, USD)
PBLS
35.72
-1.01 (-2.54%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.73B
Price/Sales
31938.25
Ent value
3.77B
Price/Book
4.51
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 39.77 |
| Daily high | 40.13 |
| Daily low | 38.33 |
| Daily Volume | 501K |
| All-time high | 41.32 |
| 1y analyst estimate | 41.75 |
| Beta | - |
| EPS (TTM) | -5.91 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PBLS | S&P500 | |
| Current price drop from All-time high | -13.55% | -2.63% |
| Highest price drop | -17.49% | -56.47% |
| Date of highest drop | 15 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -4.33% | -10.69% |
| Avg time to new high | 5 days | 12 days |
| Max time to new high | 16 days | 1805 days |
News
